The role of notch receptors in transcriptional regulation

Journal of Cellular Physiology

Volumn 230, Issue 5, 2015, Pages 982-988

  Wang, Hongfang ^a   Zang, Chongzhi ^b   Liu, X Shirley ^b   Aster, Jon C ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NOTCH RECEPTOR; UNTRANSLATED RNA; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE BINDING PROTEIN;

CHROMATIN; GENE REPRESSION; GENOMICS; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; ANIMAL; DNA RESPONSIVE ELEMENT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM;

ANIMALS; GENE EXPRESSION REGULATION; HUMANS; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE-BINDING PROTEIN; RECEPTORS, NOTCH; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 84921673788     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24872     Document Type: Review

References (49)

1. Andersson ER, Sandberg R, Lendahl U. 2011. Notch signaling: Simplicity in design, versatility in function. Development 138:3593-3612.
2. Arnett KL, Hass M, McArthur DG, Ilagan MX, Aster JC, Kopan R, Blacklow SC. 2010. Structural and mechanistic insights into cooperative assembly of dimeric Notch transcription complexes. Nat Struct Mol Biol 17:1312-1317.
3. Aster JC, Pear WS, Blacklow SC. 2008. Notch signaling in leukemia. Annu Rev Pathol 3:587-613.
4. Borggrefe T, Oswald F. 2009. The Notch signaling pathway: Transcriptional regulation at Notch target genes. Cell Mol Life Sci 66:1631-1646.
5. Bray S, Musisi H, Bienz M. 2005. Bre1 is required for Notch signaling and histone modification. Dev Cell 8:279-286.
6. Brimer N, Lyons C, Wallberg AE, Vande Pol. 2012. Cutaneous papillomavirus E6 oncoproteins associate with MAML1 to repress transactivation and NOTCH signaling. Oncogene 31:4639-4646.
7. Castel D, Mourikis P, Bartels SJ, Brinkman AB, Tajbakhsh S, Stunnenberg HG. 2013. Dynamic binding of RBPJ is determined by Notch signaling status. Genes Dev 27:1059-1071.
8. Collins KJ, Yuan Z, Kovall RA. 2014. Structure and function of the CSL-KyoT2 corepressor complex: A negative regulator of Notch signaling. Structure 22:70-81.
9. Cuddapah S, Jothi R, Schones DE, Roh TY, Cui K, Zhao K. 2009. Global analysis of the insulator binding protein CTCF in chromatin barrier regions reveals demarcation of active and repressive domains. Genome Res 19:24-32.
10. Di Stefano L, Walker JA, Burgio G, Corona DF, Mulligan P, Naar AM, Dyson NJ. 2011. Functional antagonism between histone H3K4 demethylases in vivo. Genes Dev 25:17-28.
11. Dowen JM, Fan ZP, Hnisz D, Ren G, Abraham BJ, Zhang LN, Weintraub AS, Schuijers J, Lee TI, Zhao K, Young RA. 2014. Control of cell identity genes occurs in insulated neighborhoods in mammalian chromosomes. Cell 159:374-387.
12. Durinck K, Wallaert A, Van de Walle I, Van Loocke W, Volders P-J, Vanhauwaert S, Geerdens E, Benoit Y, Van Roy N, Poppe B, Soulier J, Cools J, Mestdagh P, Vandesompele J, Rondou P, Van Vlierberghe P, Taghon T, Speleman F. 2014. The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia. Haematologica 99:1799-1807.
13. Fryer CJ, White JB, Jones KA. 2004. Mastermind recruits CycC: CDK8 to phosphorylate the Notch ICD and coordinate activation with turnover. Mol Cell 16:509-520.
14. Geimer Le Lay, Oravecz AS, Mastio A, Jung J, Marchal C, Ebel P, Dembele C, Jost D, Le Gras B, Thibault S, Borggrefe C, Kastner T, Chan P. 2014. The tumor suppressor Ikaros shapes the repertoire of notch target genes in T cells. Sci Signaling 7:28.
15. Guarani V, Deflorian G, Franco CA, Kruger M, Phng LK, Bentley K, Toussaint L, Dequiedt F, Mostoslavsky R, Schmidt MH, Zimmermann B, Brandes RP, Mione M, Westphal CH, Braun T, Zeiher AM, Gerhardt H, Dimmeler S, Potente M. 2011. Acetylation-dependent regulation of endothelial Notch signalling by the SIRT1 deacetylase. Nature 473:234-238.
16. Handoko L, Xu H, Li G, Ngan CY, Chew E, Schnapp M, Lee CW, Ye C, Ping JL, Mulawadi F, Wong E, Sheng J, Zhang Y, Poh T, Chan CS, Kunarso G, Shahab A, Bourque G, Cacheux-Rataboul V, Sung WK, Ruan Y, Wei CL. 2011. CTCF-mediated functional chromatin interactome in pluripotent cells. Nat Genetics 43:630-638.
17. Hawkins RD, Hon GC, Yang C, Antosiewicz-Bourget JE, Lee LK, Ngo QM, Klugman S, Ching KA, Edsall LE, Ye Z, Kuan S, Yu P, Liu H, Zhang X, Green RD, Lobanenkov VV, Stewart R, Thomson JA, Ren B. 2011. Dynamic chromatin states in human ES cells reveal potential regulatory sequences and genes involved in pluripotency. Cell Res 21:1393-1409.
18. Herranz D, Ambesi-Impiombato A, Palomero T, Schnell SA, Belver L, Wendorff AA, Xu L, Castillo-Martin M, Llobet-Navas D, Cordon-Cardo C, Clappier E, Soulier J, Ferrando AA. 2014. A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia. Nat Med 20:1130-1137.
19. Hnisz D, Abraham BJ, Lee TI, Lau A, Saint-Andre V, Sigova AA, Hoke HA, Young RA. 2013. Super-enhancers in the control of cell identity and disease. Cell 155:934-947.
20. Hori K, Cholewa-Waclaw J, Nakada Y, Glasgow SM, Masui T, Henke RM, Wildner H, Martarelli B, Beres TM, Epstein JA, Magnuson MA, Macdonald RJ, Birchmeier C, Johnson JE. 2008. A nonclassical bHLH Rbpj transcription factor complex is required for specification of GABAergic neurons independent of Notch signaling. Genes Dev 22:166-178.
21. Jeannet R, Mastio J, Macias-Garcia A, Oravecz A, Ashworth T, Geimer Le Lay, Jost AS, Le Gras B, Ghysdael S, Gridley J, Honjo T, Radtke T, Aster F, Chan JC, Kastner S. 2010. Oncogenic activation of the Notch1 gene by deletion of its promoter in Ikaros-deficient T-ALL. Blood 116:5443-5454.
22. Kagey MH, Newman JJ, Bilodeau S, Zhan Y, Orlando DA, van Berkum NL, Ebmeier CC, Goossens J, Rahl PB, Levine SS, Taatjes DJ, Dekker J, Young RA. 2010. Mediator and cohesin connect gene expression and chromatin architecture. Nature 467:430-435.
23. Kopan R, Ilagan MX. 2009. The canonical Notch signaling pathway: Unfolding the activation mechanism. Cell 137:216-233.
24. Krejci A, Bray S. 2007. Notch activation stimulates transient and selective binding of Su(H)/CSL to target enhancers. Genes Dev 21:1322-1327.
25. Lake RJ, Tsai P-F, Choi I, Won K-J, Fan H-Y. 2014. RBPJ, the major transcriptional effector of Notch signaling, remains associated with chromatin throughout mitosis, suggesting a role in mitotic bookmarking. PLoS Genetics 10:e1004204.
26. Lan K, Verma SC, Murakami M, Bajaj B, Kaul R, Robertson ES. 2007. Kaposi's sarcoma herpesvirus-encoded latency-associated nuclear antigen stabilizes intracellular activated Notch by targeting the Sel10 protein. Proc Nat Acad Sci USA 104:16287-16292.
27. Li N, Fassl A, Chick J, Inuzuka H, Li X, Mansour MR, Liu L, Wang H, King B, Shaik S, Gutierrez A, Ordureau A, Otto T, Kreslavsky T, Baitsch L, Bury L, Meyer CA, Ke N, Mulry KA, Kluk MJ, Roy M, Kim S, Zhang X, Geng Y, Zagozdzon A, Jenkinson S, Gale RE, Linch DC, Zhao JJ, Mullighan CG, Harper JW, Aster JC, Aifantis I, von Boehmer H, Gygi SP, Wei W, Look AT, Sicinski P. 2014. Cyclin C is a haploinsufficient tumour suppressor. Nat Cell Biol 16:1080-1091.
28. Liefke R, Oswald F, Alvarado C, Ferres-Marco D, Mittler G, Rodriguez P, Dominguez M, Borggrefe T. 2010. Histone demethylase KDM5A is an integral part of the core Notch-RBP-J repressor complex. Genes Dev 24:590-601.
29. Liu H, Chi AW, Arnett KL, Chiang MY, Xu L, Shestova O, Wang H, Li YM, Bhandoola A, Aster JC, Blacklow SC, Pear WS. 2010. Notch dimerization is required for leukemogenesis and T-cell development. Genes Dev 24:2395-2407.
30. Loven J, Hoke HA, Lin CY, Lau A, Orlando DA, Vakoc CR, Bradner JE, Lee TI, Young RA. 2013. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell 153:320-334.
31. Medyouf H, Gusscott S, Wang H, Tseng JC, Wai C, Nemirovsky O, Trumpp A, Pflumio F, Carboni J, Gottardis M, Pollak M, Kung AL, Aster JC, Holzenberger M, Weng AP. 2011. High-level IGF1R expression is required for leukemia-initiating cell activity in T-ALL and is supported by Notch signaling. J Exp Med 208:1809-1822.
32. Meyers JM, Spangle JM, Munger K. 2013. The human papillomavirus type 8 E6 protein interferes with NOTCH activation during keratinocyte differentiation. J Virol 87:4762-4767.
33. Mulligan P, Yang F, Di Stefano L, Ji JY, Ouyang J, Nishikawa JL, Toiber D, Kulkarni M, Wang Q, Najafi-Shoushtari SH, Mostoslavsky R, Gygi SP, Gill G, Dyson NJ, Naar AM. 2011. A SIRT1-LSD1 corepressor complex regulates Notch target gene expression and development. Mol Cell 42:689-699.
34. O'Neil J, Grim J, Strack P, Rao S, Tibbitts D, Winter C, Hardwick J, Welcker M, Meijerink JP, Pieters R, Draetta G, Sears R, Clurman BE, Look AT. 2007. FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors. J Exp Med 204:1813-1824.
35. Ohtani Y, Wang H, Zang C, Arnett KL, Bailis W, Ho Y, Knoechel B, Lanauze C, Louis L, Chung Y, Schug J, Blobel G, Liebhaber SA, Bernstein BE, Blacklow SC, Liu XS, Aster JC, Pear WS. 2014. epublished 11/03/2014 Long-range enhancer activity determines Myc sensitivity to Notch inhibitors in T cell leukemia. Proc Nat Acad Sci USA.
36. Parker SCJ, Stitzel ML, Taylor DL, Orozco JM, Erdos MR, Akiyama JA, van Bueren KL, Chines PS, Narisu N, Black BL, Visel A, Collins FS. 2013. Chromatin stretch enhancer stated drive cell-specific gene regulation and harbor human disease risk variants. Proc Natl Acad Sci USA 110:17921-17926.
37. Popko-Scibor AE, Lindberg MJ, Hansson ML, Holmlund T, Wallberg AE. 2011. Ubiquitination of Notch1 is regulated by MAML1-mediated p300 acetylation of Notch1. Biochem Biophys Res Comm 416:300-306.
38. Qin H, Wang J, Liang Y, Taniguchi Y, Tanigaki K, Han H. 2004. RING1 inhibits transactivation of RBP-J by Notch through interaction with LIM protein KyoT2. Nucl Acids Res 32:1492-1501.
39. Saint Just, Ribeiro M, Hansson ML, Wallberg AE. 2007. A proline repeat domain in the Notch co-activator MAML1 is important for the p300-mediated acetylation of MAML1. Biochem J 404:289-298.
40. South AP, Cho RJ, Aster JC. 2012. The double-edged sword of Notch signaling in cancer. Sem Cell Dev Biol 23:458-464.
41. Stephens PJ, Davies HR, Mitani Y, Van Loo P, Shlien A, Tarpey PS, Papaemmanuil E, Cheverton A, Bignell GR, Butler AP, Gamble J, Gamble S, Hardy C, Hinton J, Jia M, Jayakumar A, Jones D, Latimer C, McLaren S, McBride DJ, Menzies A, Mudie L, Maddison M, Raine K, Nik-Zainal S, O'Meara S, Teague JW, Varela I, Wedge DC, Whitmore I, Lippman SM, McDermott U, Stratton MR, Campbell PJ, El-Naggar AK, Futreal PA. 2013. Whole exome sequencing of adenoid cystic carcinoma. J Clin Inv 123:2965-2968.
42. Stoeck A, Lejnine S, Truong A, Pan L, Wang H, Zang C, Yuan J, Ware C, MacLean J, Garrett-Engele PW, Kluk M, Laskey J, Haines BB, Moskaluk C, Zawel L, Fawell S, Gilliland G, Zhang T, Kremer BE, Knoechel B, Bernstein BE, Pear WS, Liu XS, Aster JC, Sathyanarayanan S. 2014. Discovery of biomarkers predictive of GSI response in triple-negative breast cancer and adenoid cystic carcinoma. Cancer Discov 4:1154-1167.
43. Tan MJ, White EA, Sowa ME, Harper JW, Aster JC, Howley PM. 2012. Cutaneous beta-human papillomavirus E6 proteins bind Mastermind-like coactivators and repress Notch signaling. Proc Nat Acad Sci USA 109:E1473-E1480.
44. Terriente-Felix A, Li J, Collins S, Mulligan A, Reekie I, Bernard F, Krejci A, Bray S. 2013. Notch cooperates with Lozenge/Runx to lock haemocytes into a differentiation programme. Development 140:926-937.
45. Trimarchi T, Bilal E, Ntziachristos P, Fabbri G, Dalla-Favera R, Tsirigos A, Aifantis I. 2014. Genome-wide mapping and characterization of notch-regulated long noncoding RNAs in acute leukemia. Cell 158:593-606.
46. Wang J, Scully K, Zhu X, Cai L, Zhang J, Prefontaine GG, Krones A, Ohgi KA, Zhu P, Garcia-Bassets I, Liu F, Taylor H, Lozach J, Jayes FL, Korach KS, Glass CK, Fu XD, Rosenfeld MG. 2007. Opposing LSD1 complexes function in developmental gene activation and repression programmes. Nature 446:882-887.
47. Wang H, Zou J, Zhao B, Johannsen E, Ashworth T, Wong H, Pear WS, Schug J, Blacklow SC, Arnett KL, Bernstein BE, Kieff E, Aster JC. 2011. Genome-wide analysis reveals conserved and divergent features of Notch1/RBPJ binding in human and murine T-lymphoblastic leukemia cells. Proc Nat Acad Sci USA 108:14908-14913.
48. Wang H, Zang C, Taing L, Arnett KL, Wong YJ, Pear WS, Blacklow SC, Liu XS, Aster JC. 2014. NOTCH1-RBPJ complexes drive target gene expression through dynamic interactions with superenhancers. Proc Nat Acad Sci USA 111:705-710.
49. Yatim A, Benne C, Sobhian B, Laurent-Chabalier S, Deas O, Judde JG, Lelievre JD, Levy Y, Benkirane M. 2012. NOTCH1 nuclear interactome reveals key regulators of its transcriptional activity and oncogenic function. Mol Cell 48:445-458.